Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype

This publication has 18 references indexed in Scilit:

• Expression of p16INK4A and p14ARF in hematological malignancies
  Leukemia, 1999
• Frequent Methylation Silencing of p15INK4b(MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas
  Blood, 1999
• Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia
  Leukemia, 1999
• The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer
  Annual Review of Medicine, 1999
• Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells
  Leukemia, 1998
• Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRb, p16INK4A) in childhood acute lymphoblastic leukemia
  International Journal of Cancer, 1997
• Incidence and Clinical Significance of CDKN2/MTS1/P16^ink4AND MTS2/P15^ink4BGene Deletions in Childhood Acute Lymphoblastic Leukemia
  Pediatric Hematology and Oncology, 1997
• Transfer of p16 ^inka /CDKN2 gene in leukaemic cell lines inhibits cell proliferation
  British Journal of Haematology, 1996
• p16^ink4aGene and Hematological Malignancies
  Leukemia & Lymphoma, 1996
• Mutations and altered expression of p16INK4 in human cancer.
  Proceedings of the National Academy of Sciences, 1994